68 filings
8-K
AXIM
Axim Biotechnologies, Inc.
21 Mar 24
Entry into a Material Definitive Agreement
3:47pm
8-K
AXIM
Axim Biotechnologies, Inc.
13 Feb 24
Entry into a Material Definitive Agreement
5:16pm
8-K
AXIM
Axim Biotechnologies, Inc.
28 Dec 23
Entry into a Material Definitive Agreement
11:59am
8-K
AXIM
Axim Biotechnologies, Inc.
2 Jun 23
Entry into a Material Definitive Agreement
2:51pm
8-K
AXIM
Axim Biotechnologies, Inc.
30 May 23
Entry into a Material Definitive Agreement
3:50pm
8-K
2pru0qs lgbo
25 May 23
Departure of Directors or Certain Officers
4:04pm
8-K
2m6jcw2 a4
27 Jan 23
Entry into a Material Definitive Agreement
4:07pm
8-K
8zgq8yegxzc2o6dkz
19 Sep 22
Company to Sell, Distribute AXIM’s Readers and Three Proprietary Tests Designed for Diagnosis of Dry Eye Disease Globally Through New Agreement
4:14pm
8-K
v8h up0i2oa3vo7acov
29 Aug 22
Entry into a Material Definitive Agreement
3:08pm
8-K
xqr8c0
9 Mar 22
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
4:37pm
8-K
cz1gsf
16 Feb 22
Entry into a Material Definitive Agreement
4:33pm
8-K
2urquhctl3 49dt
12 Jan 22
Departure of Directors or Certain Officers
12:00am
8-K
1prbrt
7 Jan 22
Departure of Directors or Certain Officers
4:21pm
8-K
dizgln81izo2twpqgi
4 Aug 21
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
12:00am
8-K
vxg1ei
14 May 21
Entry into a Material Definitive Agreement
4:07pm
8-K
zfgh8prvtmuw3c6 r39a
24 Jul 20
Departure of Directors or Certain Officers
12:00am
8-K/A
ltlahtkp7o zd08
29 May 20
Index to Combined Financial Statements
12:00am
8-K
6ao9r
14 May 20
Other Events
5:06pm
8-K
enay 5biw7mm
13 May 20
AXIM® Biotechnologies Issues Update Letter to Shareholders
12:00am
8-K
s0615vjm88n
12 May 20
Entry into a Material Definitive Agreement
5:02pm